Expert Review of Pharmacoeconomics & Outcomes Research, Volume 19, Issue 1 (2019)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 19, Issue 1 (2019)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Volume 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
The evolving role of patient advocates in rare cancers: opportunities and challenges
Ornella Gonzato & Alessandro Gronchi
Pages: 1-3
Published online: 27 Sep 2018
First Page PreviewforThe evolving role of patient advocates in rare cancers: opportunities and challenges | Full Text | References | PDF (425.7 KB) | EPUB
  • 1566 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Cost analysis of type 2 diabetes mellitus treatment in economically developed countries
Sara Ramzan, Peter Timmins, Syed Shahzad Hasan & Zaheer-Ud-Din Babar
Pages: 5-14
Published online: 04 Sep 2018
AbstractforCost analysis of type 2 diabetes mellitus treatment in economically developed countries | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 400 Views
  • 14 CrossRef citations
  • 0Altmetric
Review
Cost-effectiveness of somatostatin analogues in the treatment of acromegaly
Ewa Orlewska, Renata Stępień & Katarzyna Orlewska
Pages: 15-25
Published online: 03 Sep 2018
AbstractforCost-effectiveness of somatostatin analogues in the treatment of acromegaly | Full Text | References | PDF (824.1 KB) | EPUB
  • 218 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review
Jean-Baptiste Briere, Kevin Bowrin, Craig Coleman, Laurent Fauchier, Pierre Levy, Kerstin Folkerts, Mondher Toumi, Vanessa Taieb, Aurélie Millier & Olivia Wu
Pages: 27-36
Published online: 19 Sep 2018
AbstractforReal-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review | Full Text | References | PDF (965.1 KB) | EPUB | Supplemental
  • 746 Views
  • 15 CrossRef citations
  • 0Altmetric
Review
Cross-national drug price comparisons with economic weights in external reference pricing in Germany
Jörg Mahlich, Jörn Sindern & Moritz Suppliet
Pages: 37-43
Published online: 14 Oct 2018
AbstractforCross-national drug price comparisons with economic weights in external reference pricing in Germany | Full Text | References | PDF (794.4 KB) | EPUB
  • 342 Views
  • 6 CrossRef citations
  • 0Altmetric

Original Research

Article
Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin
Antoni Sicras-Mainar, Javier Rejas-Gutiérrez, María Pérez-Paramo, Luis Sánchez-Alvarez, Ruth Navarro-Artieda & Josep Darbà
Pages: 45-57
Published online: 17 Sep 2018
AbstractforConsequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin | Full Text | References | PDF (1.3 MB) | EPUB
  • 433 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Drug attributes associated with the selection of drugs for reimbursement: a pilot stated preferences experiment with Canadian stakeholders
Wiesława Dominika Wranik, Christopher Skedgel & Min Hu
Pages: 59-69
Published online: 13 Sep 2018
AbstractforDrug attributes associated with the selection of drugs for reimbursement: a pilot stated preferences experiment with Canadian stakeholders | Full Text | References | PDF (1.5 MB) | EPUB
  • 146 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Factors associated with physicians’ decision to discontinue or down-titrate sulfonylureas for type 2 diabetes patients
Pedro Laires, Karen Kurtyka, Edward A. Witt, Ying Qiu, Shengsheng Yu & Kristy Iglay
Pages: 71-79
Published online: 26 Sep 2018
AbstractforFactors associated with physicians’ decision to discontinue or down-titrate sulfonylureas for type 2 diabetes patients | Full Text | References | PDF (996.3 KB) | EPUB | Supplemental
  • 124 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Impact of the implementation of a Fracture Liaison Service on pharmaceutical expenses for osteoporosis compared to an area without an FLS
Antonio Naranjo, Soledad Ojeda-Bruno, Aida Saavedra, Amparo Molina & Miguel Negrín
Pages: 81-87
Published online: 06 Sep 2018
AbstractforImpact of the implementation of a Fracture Liaison Service on pharmaceutical expenses for osteoporosis compared to an area without an FLS | Full Text | References | PDF (1.1 MB) | EPUB
  • 123 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients
Hosein Ameri, Mahmood Yousefi, Mehdi Yaseri, Azin Nahvijou, Mohammad Arab & Ali Akbari Sari
Pages: 89-96
Published online: 03 Sep 2018
AbstractforMapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients | Full Text | References | PDF (822.5 KB) | EPUB | Supplemental
  • 330 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
Creating a personalized evaluation framework for patient-reported outcomes: an illustration using the EQ-5D visual analogue scale
M. Reaney, L. Stassek, M. Martin, K. McCarrier, A. Slagle, A. Shields & C. J. Gwaltney
Pages: 97-104
Published online: 06 Sep 2018
AbstractforCreating a personalized evaluation framework for patient-reported outcomes: an illustration using the EQ-5D visual analogue scale | Full Text | References | PDF (992.7 KB) | EPUB
  • 118 Views
  • 3 CrossRef citations
  • 0Altmetric

Explore articles